The inferior vena cava filters market has seen considerable growth due to a variety of factors.
•The market size for inferior vena cava filters has seen robust growth in recent times. The predictions indicate a rise from $5.43 billion in 2024 to $5.83 billion in 2025, marking a compound annual growth rate (CAGR) of 7.4%.
The significant growth in the historic period is a result of an increased incidence of deep vein thrombosis, a surge in the aging population, proactive steps to prevent pulmonary embolism, advancements in filter designs, and heightened awareness through programs and medical education.
The inferior vena cava filters market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for inferior vena cava filters is anticipated to experience robust growth in the forthcoming years, escalating to "$8.11 billion by 2029 at a compound annual growth rate (CAGR) of 8.6%.
Potential reasons for this projected growth during the forecast period include a rise in surgical procedures and trauma incidents, emphasis on outpatient settings, increase in chronic illnesses and comorbidities, trends in the aging population worldwide, and broadened access to health services. Dominant tendencies for the forecast period involve improved abilities to capture thrombus, investigation into additional anticoagulant treatments, strengthened partnerships between manufacturers and healthcare providers, ongoing regulatory observance and tracking, as well as the development of awareness and educational efforts.
The surge in the instances of venous thromboembolism is anticipated to drive the growth of the inferior vena cava filter market. Venous thromboembolism, or VTE, denotes the occurrence of blood clots within veins, which can cause severe disability or even death if not treated promptly. Inferior vena cava filters are medical instruments designed to prevent the passage of a blood clot to the heart or lungs, thereby averting venous thromboembolism. For example, in February 2023, data released by the Centers for Disease Control and Prevention, a public health institution based in Georgia, estimated that approximately 900,000 people are likely to be impacted by venous thromboembolism. Moreover, VTE leads to the death of about 60,000 to 100,000 Americans annually. Therefore, the escalating occurrence of venous thromboembolism is spurring the rise of the inferior vena cava filter market.
The inferior vena cava filters market covered in this report is segmented –
1) By Product: Retrievable Inferior Vena Cava (IVC) Filters, Permanent Inferior Vena Cava (IVC) Filters
2) By Material: Non-Ferromagnetic Materials, Ferromagnetic Materials
3) By Application: Treatment Of Venous Thromboembolism (VTE), Prevention Of Pulmonary Embolism (PE), Other Applications
4) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Retrievable IVC Filters: Optional Retrievable Filters, Temporary Filters
2) By Permanent IVC Filters: Stainless Steel Filters, Titanium Filters, Other Permanent Filters
Leading companies in the inferior vena cava (IVC) filters market are developing advanced IVC filters to better patient outcomes and boost filter recovery rates. The IVC filter is designed to stop blood clots from reaching the lungs, thereby reducing the risk of pulmonary embolism in patients who can't use anticoagulants. For example, in April 2022, Royal Philips, a health technology firm based in Netherlands, introduced the CavaClear IVC filter removal laser sheath. It provides a less invasive method for safely extracting embedded IVC filters. By using advanced circumferential tissue ablation, it increases the efficiency of the operation and decreases retrieval attempts, thus meeting a critical requirement in the IVC filter market.
Major companies operating in the inferior vena cava filters market include:
• B. Braun Melsungen AG
• Argon Medical Devices Inc.
• Boston Scientific Corporation
• Cook Medical LLC
• Braile Biomédica Indústria Comércio e Representações Ltd.
• Lifetech Scientific Corporation
• VENITI Inc.
• Cordis Corporation
• Bard
• Becton Dickinson and Company
• Cardinal Health Inc.
• C. R. Bard Inc.
• LeMaitre Vascular Inc.
• Medtronic plc
• Merit Medical Systems Inc.
• Teleflex Incorporated
• RA Medical Systems
• ETEX Corporation
• OptiMed Medizinische Instrumente GmbH
• Blue Sail Medical Co. Ltd.
• Penumbra Inc.
North America was the largest region in the inferior vena cava filters market in 2024. The regions covered in the inferior vena cava filters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa